NasdaqCM - Nasdaq Real Time Price USD
Corcept Therapeutics Incorporated (CORT)
70.49
-0.69
(-0.97%)
As of 11:10:41 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,813,335 | 45 |
| Sales | 704,181 | 33 |
| Net Shares Purchased (Sold) | 1,109,154 | 78 |
| Total Insider Shares Held | 12.18M | -- |
| % Net Shares Purchased (Sold) | 10.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GUYER WILLIAM Officer | Conversion of Exercise of derivative security at price 21.65 per share. | Direct | 433,000 | Jun 10, 2025 |
| SWISHER DANIEL N JR Director | Conversion of Exercise of derivative security at price 14.08 per share. | Direct | 30,976 | Jun 10, 2025 |
| GUYER WILLIAM Officer | Sale at price 72.36 - 72.75 per share. | Direct | 1,448,475 | Jun 10, 2025 |
| SWISHER DANIEL N JR Director | Sale at price 70.61 per share. | Direct | 155,342 | Jun 10, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Conversion of Exercise of derivative security at price 13.56 per share. | Direct | 67,800 | Jun 2, 2025 |
| MADUCK SEAN Officer | Conversion of Exercise of derivative security at price 71.68 per share. | Direct | 1,433,600 | Jun 2, 2025 |
| MADUCK SEAN Officer | Sale at price 77.91 - 80.77 per share. | Direct | 1,581,686 | Jun 2, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Sale at price 77.97 - 78.65 per share. | Direct | 390,218 | Jun 2, 2025 |
| BELANOFF JOSEPH K Chief Executive Officer | Sale at price 78.42 - 85.01 per share. | Indirect | 3,314,310 | Jun 2, 2025 |
| ROBB GARY CHARLES Officer | Stock Award(Grant) at price 0.00 - 71.68 per share. | Direct | 71,465 | Jun 2, 2025 |
| MOKARI ATABAK Chief Financial Officer | Stock Award(Grant) at price 0.00 - 71.68 per share. | Direct | 55,552 | Jun 2, 2025 |
| MADUCK SEAN Officer | Stock Award(Grant) at price 0.00 - 71.68 per share. | Direct | 1,497,252 | Jun 2, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Stock Award(Grant) at price 0.00 - 71.68 per share. | Direct | 53,688 | Jun 2, 2025 |
| MADUCK SEAN Officer | Conversion of Exercise of derivative security at price 3.88 per share. | Direct | 38,800 | May 29, 2025 |
| MADUCK SEAN Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 29, 2025 |
| ROBB GARY CHARLES Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 20, 2025 |
| ROBB GARY CHARLES Officer | Sale at price 75.85 per share. | Direct | 172,862 | May 20, 2025 |
| GUYER WILLIAM Officer | Conversion of Exercise of derivative security at price 21.65 per share. | Direct | 698,472 | May 16, 2025 |
| MAHONEY DAVID L Director | Conversion of Exercise of derivative security at price 6.55 per share. | Direct | 196,500 | May 16, 2025 |
| GUYER WILLIAM Officer | Sale at price 74.17 per share. | Direct | 2,393,014 | May 16, 2025 |
| MAHONEY DAVID L Director | Sale at price 74.17 - 74.65 per share. | Direct | 2,030,452 | May 16, 2025 |
| SWISHER DANIEL N JR Director | Conversion of Exercise of derivative security at price 12.13 - 14.08 per share. | Direct | 27,466 | May 12, 2025 |
| SWISHER DANIEL N JR Director | Sale at price 71.55 - 72.17 per share. | Direct | 158,526 | May 12, 2025 |
| GUYER WILLIAM Officer | Conversion of Exercise of derivative security at price 21.65 per share. | Direct | 152,849 | May 6, 2025 |
| GUYER WILLIAM Officer | Sale at price 74.31 per share. | Direct | 524,653 | May 6, 2025 |
| MADUCK SEAN Officer | Conversion of Exercise of derivative security at price 5.05 per share. | Direct | 199,020 | May 2, 2025 |
| MADUCK SEAN Officer | Sale at price 71.94 - 72.98 per share. | Direct | 2,842,769 | May 2, 2025 |
| BELANOFF JOSEPH K Chief Executive Officer | Sale at price 72.52 - 73.22 per share. | Indirect | 2,915,922 | May 2, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Conversion of Exercise of derivative security at price 13.56 per share. | Direct | 126,786 | May 1, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Sale at price 71.96 per share. | Direct | 672,781 | May 1, 2025 |
| SWISHER DANIEL N JR Director | Conversion of Exercise of derivative security at price 12.13 per share. | Direct | 26,686 | Apr 10, 2025 |
| SWISHER DANIEL N JR Director | Sale at price 70.22 per share. | Direct | 154,484 | Apr 10, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Conversion of Exercise of derivative security at price 13.56 - 19.26 per share. | Direct | 3,318,214 | Apr 1, 2025 |
| GUYER WILLIAM Officer | Conversion of Exercise of derivative security at price 21.65 per share. | Direct | 14,679 | Apr 1, 2025 |
| MADUCK SEAN Officer | Conversion of Exercise of derivative security at price 5.05 - 8.27 per share. | Direct | 829,980 | Apr 1, 2025 |
| GUYER WILLIAM Officer | Sale at price 91.93 per share. | Direct | 62,329 | Apr 1, 2025 |
| MADUCK SEAN Officer | Sale at price 91.93 - 102.16 per share. | Direct | 10,108,249 | Apr 1, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Sale at price 91.93 - 102.48 per share. | Direct | 20,153,265 | Apr 1, 2025 |
| BELANOFF JOSEPH K Chief Executive Officer | Sale at price 91.93 - 94.72 per share. | Indirect | 3,357,037 | Apr 1, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Conversion of Exercise of derivative security at price 13.56 per share. | Direct | 5,709 | Mar 24, 2025 |
| MADUCK SEAN Officer | Conversion of Exercise of derivative security at price 5.05 per share. | Direct | 8,570 | Mar 24, 2025 |
| MADUCK SEAN Officer | Sale at price 60.58 per share. | Direct | 102,804 | Mar 24, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Sale at price 60.58 per share. | Direct | 25,504 | Mar 24, 2025 |
| BELANOFF JOSEPH K Chief Executive Officer | Sale at price 60.83 per share. | Indirect | 120,084 | Mar 24, 2025 |
| ROBB GARY CHARLES Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| SWISHER DANIEL N JR Director | Conversion of Exercise of derivative security at price 12.13 per share. | Direct | 26,686 | Mar 10, 2025 |
| SWISHER DANIEL N JR Director | Sale at price 53.60 per share. | Direct | 117,920 | Mar 10, 2025 |
| GUYER WILLIAM Officer | Conversion of Exercise of derivative security at price 19.26 per share. | Direct | 385,200 | Mar 4, 2025 |
| GUYER WILLIAM Officer | Sale at price 59.07 per share. | Direct | 1,181,400 | Mar 4, 2025 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Conversion of Exercise of derivative security at price 13.56 per share. | Direct | 62,091 | Mar 3, 2025 |
Related Tickers
ADMA ADMA Biologics, Inc.
20.58
-4.72%
KRYS Krystal Biotech, Inc.
138.03
-1.64%
CYTK Cytokinetics, Incorporated
33.53
+0.99%
CPRX Catalyst Pharmaceuticals, Inc.
23.67
-2.55%
PTGX Protagonist Therapeutics, Inc.
56.18
-0.26%
APGE Apogee Therapeutics, Inc.
42.78
+2.19%
MRUS Merus N.V.
55.16
-0.42%
RYTM Rhythm Pharmaceuticals, Inc.
63.69
+1.06%
KYMR Kymera Therapeutics, Inc.
46.70
-1.25%
EXEL Exelixis, Inc.
41.55
-0.56%